100 / 127
98
A interface vítreo-retiniana
AVM, TVM e BM
25 Perguntas e respostas
REFERÊNCIAS
1.
Wong SC, Capone A Jr. Microplasmin (ocri-
plasmin) in pediatric vitreoretinal surgery, up-
date and review. Retina 2013;33:339-48.
2.
Sebag J. Age-related differences in hu-
man vitreoretinal interface. Arch Ophthalmol
1991;109:966-71.
3.
Hubbard GB. Surgical management of reti-
nopathy of prematurity. Curr Opin Ophthal-
mol 2008;19(5):384-90.
4.
Trese MT, Capone A, Hartnett ME. Retinopa-
thy of Prematuty: Evolution of Stages 4 and
5 ROP and Management. In: Pediatric retina.
Hartnett ME (Ed). Chapter 27. Philadelphia:
Lippincott Williams & wilkins; 2005. p. 411-24.
5.
An International Committee for the classi-
fication or Retinopathy of Prematurity. The
International Classification of Retinopathy
of prematurity revisited. Arch Ophthamol.
2005;123(7):991-9.
6.
Douane’s Foundation of Clinical Ophthal-
mology. Sebag J, Kenneth M, Yee P. Vit-
reous: From Biochemistry to Clinical Rele-
vance. Volume 1, Chapter 16. JB Lippincot
1991.
7.
Wilson C, Theadorou M, Cocker KD, Field-
er AR. The temporal retinal vessels angle
and infant born preterm. Br J Ophthalmol
2006;90:702-4.
Figura 12.
Membrana avascular não exercendo
tracção, resquício de proliferação
(ROP estadio 3) pós injecção de
bevacizumab. De notar a aparente
normal vascularização da retina anterior
à membrana.